PHVS

Pharvaris N.V. Ordinary Shares (PHVS)

About Pharvaris N.V. Ordinary Shares (PHVS)

Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Johannes Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.

Details

Daily high

$17.22

Daily low

$16.02

Price at open

$16.09

52 Week High

$25.50

52 Week Low

$11.51

Market cap

862.6M

Dividend yield

0.00%

Volume

559,870

Avg. volume

35,059

P/E ratio

-5.89

Pharvaris N.V. Ordinary Shares News